Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cancers|July 15, 2026
Radiotherapy-Associated Systemic Antitumor Responses Beyond the Classical Abscopal ParadigmYosuke Dotsu, Kazumasa Akagi, Noritaka Honda, et al.
Journal for Immunotherapy of Cancer|February 4, 2022
Chemical augmentation of mitochondrial electron transport chains tunes T cell activation threshold in tumorsYosuke Dotsu, Daisuk Muraoka, Naohisa Ogo, et al.
Internal Medicine (Tokyo, Japan)|April 20, 2017
Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma PigmentosumMakoto Sumiyoshi, Hiroshi Soda, Noriaki Sadanaga, et al.
Anticancer Research|July 26, 2017
Adrenal Insufficiency Related to Anti-Programmed Death-1 TherapyRyo Ariyasu, Atsushi Horiike, Takahiro Yoshizawa, et al.
Internal Medicine (Tokyo, Japan)|April 7, 2017
Pulmonary Artery Sarcoma Overexpressing Platelet-derived Growth Factor Receptor αShinnosuke Takemoto, Hiroshi Soda, Keisuke Iwasaki, et al.
Thoracic Cancer|September 26, 2018
Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanomaTakaya Ikeda, Hiroyuki Yamaguchi, Yosuke Dotsu, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibodyMasafumi Saiki, Takahiro Yoshizawa, Yosuke Dotsu, et al.
Cancer Science|September 10, 2022
Pan-HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK-rearranged lung cancerHirokazu Taniguchi, Kazumasa Akagi, Yosuke Dotsu, et al.
Pageof 4